LOXL3 may regulate the secretion of cytokines and chemokines by tumor cells, recruit immunosuppressive cells into the tumor microenvironment, and inhibit the body’s anti-tumor immune response, thereby affecting tumor prognosis (Zheng et al., 2024). The gene discussed is LOXL3; the disease is neoplasm.